Trump’s 100% Tariffs on Imported Medicines Rattle Indian Pharma Stocks
Indian pharma stocks plunged after Trump announced a 100% tariff on imported branded drugs, pressuring companies to shift manufacturing to the U.S.
Indian pharma stocks plunged after Trump announced a 100% tariff on imported branded drugs, pressuring companies to shift manufacturing to the U.S.
SUTRA 2025 to bring global leaders together in New Delhi, highlighting India’s pivotal role in advancing responsible sourcing, sustainable trade, and inclusive growth.
India’s stock market turned global laggard in 2025, with Sensex and Nifty delivering some of the weakest returns worldwide, raising questions about a potential market comeback.
Aditya Birla Housing Finance Limited launches ‘Khushi’ Home Loans, empowering Economically Weaker and Low-Income Groups with affordable, inclusive financing solutions
Trump’s executive order raising the H-1B filing fee to $100,000 sparks concern in India’s IT sector, impacting investor sentiment and contract strategies.
India aims to position at least two PSBs among the world’s top 20 banks by 2047, aligning with the Viksit Bharat vision to build globally competitive financial institutions.
IFQM held its second annual symposium in New Delhi, highlighting quality and innovation as key drivers to boost India’s global competitiveness.
India is taking a cautious approach to crypto regulation, with the government and RBI favoring partial oversight to avoid legitimizing speculative assets and potential systemic risks.
Consilio inaugurated its new Innovation Centre “Taara” in Bangalore, reflecting its vision to unite legal and technology professionals in developing cutting-edge solutions for global legal challenges.
FIIs remain cautious despite India’s strong market momentum driven by GST reforms, solid GDP growth, and rising domestic investor confidence.